These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 25744334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.
    Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS, MacDonald IM.
    Am J Ophthalmol; 2018 Sep; 193():130-142. PubMed ID: 29940166
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Visual Function and Central Retinal Structure in Choroideremia.
    Heon E, Alabduljalil T, McGuigan III DB, Cideciyan AV, Li S, Chen S, Jacobson SG.
    Invest Ophthalmol Vis Sci; 2016 Jul 01; 57(9):OCT377-87. PubMed ID: 27409497
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spectrum of Disease Severity and Phenotype in Choroideremia Carriers.
    Jauregui R, Park KS, Tanaka AJ, Cho A, Paavo M, Zernant J, Francis JH, Allikmets R, Sparrow JR, Tsang SH.
    Am J Ophthalmol; 2019 Nov 01; 207():77-86. PubMed ID: 31181178
    [Abstract] [Full Text] [Related]

  • 15. Peculiar Clinical Findings in Young Choroideremia Patients: A Retrospective Case Review.
    Mucciolo DP, Murro V, Sodi A, Passerini I, Giorgio D, Virgili G, Rizzo S.
    Ophthalmologica; 2019 Nov 01; 242(4):195-207. PubMed ID: 31416074
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy Trial.
    Aleman TS, Huckfeldt RM, Serrano LW, Pearson DJ, Vergilio GK, McCague S, Marshall KA, Ashtari M, Doan TM, Weigel-DiFranco CA, Biron BS, Wen XH, Chung DC, Liu E, Ferenchak K, Morgan JIW, Pierce EA, Eliott D, Bennett J, Comander J, Maguire AM.
    Ophthalmology; 2022 Oct 01; 129(10):1177-1191. PubMed ID: 35714735
    [Abstract] [Full Text] [Related]

  • 18. Long-term Natural History of Atrophy in Eyes with Choroideremia-A Systematic Review and Meta-analysis of Individual-Level Data.
    Shen LL, Ahluwalia A, Sun M, Young BK, Grossetta Nardini HK, Del Priore LV.
    Ophthalmol Retina; 2020 Aug 01; 4(8):840-852. PubMed ID: 32362554
    [Abstract] [Full Text] [Related]

  • 19. The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype.
    Simunovic MP, Jolly JK, Xue K, Edwards TL, Groppe M, Downes SM, MacLaren RE.
    Invest Ophthalmol Vis Sci; 2016 Nov 01; 57(14):6033-6039. PubMed ID: 27820636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.